This section of C’s Newsletter is now devoted to quick takes on breaking news. I’m working on a review of anticancer potential of epifriedelanol, as I promised to do last week, based on a poll of what subscribers want to read. Medical topics are way more tedious and time-consuming than espionage and terrorism, believe it or not.